Literature DB >> 30363091

Species differences in the developmental toxicity of procymidone-Placental transfer of procymidone in pregnant rats, rabbits, and monkeys.

Hirokazu Tarui1, Yoshitaka Tomigahara1, Hirohisa Nagahori1, Kenji Sugimoto2, Masayuki Mogi3, Satoshi Kawamura1, Naohiko Isobe1, Hideo Kaneko1.   

Abstract

To clarify species differences in the developmental toxicity of procymidone (Sumilex®, a fungicide for agricultural use), placental transfer studies were conducted using 14C-labeled procymidone in pregnant rats, rabbits, and monkeys. These studies demonstrated that maternal-to-fetal transfer of the parent compound and its hydroxylated metabolite, which are both weak anti-androgenic agents, occurred more easily than that of other metabolites, with much higher absolute concentrations achieved in the fetal circulation of rats than of rabbits or monkeys. Notably, in rats, the fetal plasma concentration of the hydroxylated metabolite was higher than that of procymidone, especially after repeated oral administration of procymidone. These results suggest that the hydroxylated metabolite is the most relevant metabolite involved in teratogenic activity in rats.

Entities:  

Keywords:  placental transfer; procymidone; species difference; toxicokinetics

Year:  2018        PMID: 30363091      PMCID: PMC6140638          DOI: 10.1584/jpestics.D17-079

Source DB:  PubMed          Journal:  J Pestic Sci        ISSN: 1348-589X            Impact factor:   1.519


  15 in total

Review 1.  The placenta: transcriptional, epigenetic, and physiological integration during development.

Authors:  Emin Maltepe; Anna I Bakardjiev; Susan J Fisher
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

2.  Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites.

Authors:  W R Kelce; E Monosson; M P Gamcsik; S C Laws; L E Gray
Journal:  Toxicol Appl Pharmacol       Date:  1994-06       Impact factor: 4.219

3.  The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro.

Authors:  J Ostby; W R Kelce; C Lambright; C J Wolf; P Mann; L E Gray
Journal:  Toxicol Ind Health       Date:  1999 Jan-Mar       Impact factor: 2.273

4.  Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism.

Authors:  W R Kelce; C R Lambright; L E Gray; K P Roberts
Journal:  Toxicol Appl Pharmacol       Date:  1997-01       Impact factor: 4.219

Review 5.  Placental transfer of drugs administered to the mother.

Authors:  G M Pacifici; R Nottoli
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

6.  The affinity of procymidone to androgen receptor in rats and mice.

Authors:  S Hosokawa; M Murakami; M Ineyama; T Yamada; A Yoshitake; H Yamada; J Miyamoto
Journal:  J Toxicol Sci       Date:  1993-05       Impact factor: 2.196

7.  Pharmacokinetics and dosimetry of the antiandrogen vinclozolin after oral administration in the rat.

Authors:  Adolfo Sierra-Santoyo; Gilberto Castañeda-Hernández; Randy A Harrison; Hugh A Barton; Michael F Hughes
Journal:  Toxicol Sci       Date:  2008-08-14       Impact factor: 4.849

8.  Metabolism of procymidone derivatives in female rats.

Authors:  Hirokazu Tarui; Jun Abe; Yoshitaka Tomigahara; Satoshi Kawamura; Hideo Kaneko
Journal:  J Agric Food Chem       Date:  2009-11-25       Impact factor: 5.279

9.  Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.

Authors:  Zhong Zuo; Yun K Tam; James Diakur; Leonard I Wiebe
Journal:  J Pharm Pharm Sci       Date:  2002 Sep-Dec       Impact factor: 2.327

Review 10.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

View more
  1 in total

1.  Researches on the evaluation of pesticide safety in humans using a pharmacokinetic approach.

Authors:  Jun Abe
Journal:  J Pestic Sci       Date:  2021-08-20       Impact factor: 2.529

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.